Drug General Information (ID: D1471)
  Drug Name
Simeprevir
  Drug Type Small molecule
  Drug Synonymous
TMC436
    Click to Show/Hide
  Disease Class 1E50-1E51: Hepatitis virus infection
  Therapeutic Class Antiinfective Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C38H47N5O7S2
  InChI 1S/C38H47N5O7S2/c1-21(2)30-20-51-35(40-30)29-18-32(26-13-14-31(49-5)22(3)33(26)39-29)50-24-16-27-28(17-24)36(45)43(4)15-9-7-6-8-10-23-19-38(23,41-34(27)44)37(46)42-52(47,48)25-11-12-25/h8,10,13-14,18,20-21,23-25,27-28H,6-7,9,11-12,15-17,19H2,1-5H3,(H,41,44)(H,42,46)/b10-8-/t23-,24-,27-,28-,38-/m1/s1
  InChIKey JTZZSQYMACOLNN-VDWJNHBNSA-N
  Canonical SMILES CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC
  External Link
Pubchem ID 24873435
CAS Number 923604-59-5
CHEBI ID 134743
TTD ID D00TLP
VARIDT ID DR00014

Drug-Drug Interaction Network
  Sunburst Graph
AM002  Affected cellular transport
AM004  Affected intra/extra-hepatic metabolism
AM006  Pharmacodynamic additive effects
AM007  Pharmacodynamic antagonistic effects
BM010  Transporter inhibition
BM017  CYP450 enzyme inhibition
BM022  CYP450 enzyme induction
BM075  Increased risk of photosensitivity reactions
BM085  Antagonize the effect of antithrombotic agents
  Relation Graph
 Full list of drugs interacting with Simeprevir
      Affected cellular transport
   Transporter inhibition Drug Num:  32
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1430
 
Rosuvastatin
 
C22H28FN3O6S
 
446157 
Major    Inter Info   
[4]
D0551
 
Edoxaban
 
C24H30ClN7O4S
 
10280735 
Major    Inter Info   
[10], [12], [13], [14]
D0562
 
Eluxadoline
 
C32H35N5O5
 
11250029 
Major    Inter Info   
[10], [15], [16]
D0739
 
Grazoprevir
 
C38H50N6O9S
 
44603531 
Major    Inter Info   
[10], [17], [18]
D0898
 
Ledipasvir
 
C49H54F2N8O6
 
67505836 
Major    Inter Info   
[19], [4]
D1388
 
Relugolix
 
C29H27F2N7O5S
 
10348973 
Major    Inter Info   
[20]
D1688
 
Venetoclax
 
C45H50ClN7O7S
 
49846579 
Major    Inter Info   
[3], [10], [21]
D0511
 
Docetaxel
 
C43H53NO14
 
148124 
Moderate    Inter Info   
[30], [3], [10], [31], [32], [33], [34], [35], [36]
D0561
 
Eltrombopag
 
C25H22N4O4
 
135449332 
Moderate    Inter Info   
[37], [11], [3], [38], [39]
D1212
 
Paclitaxel
 
C47H51NO14
 
36314 
Moderate    Inter Info   
[30], [3], [10], [31], [32], [33], [34], [35], [36]
D1213
 
Paclitaxel (protein-bound)
 
C47H51NO14
 
36314 
Moderate    Inter Info   
[30], [34], [35]
D1329
 
Pravastatin
 
C23H36O7
 
54687 
Moderate    Inter Info   
[4]
D0155
 
Bempedoic acid
 
C19H36O5
 
10472693 
Moderate    Inter Info   
[46], [17]
D0176
 
Betrixaban
 
C23H22ClN5O3
 
10275777 
Moderate    Inter Info   
[47]
D0182
 
Binimetinib
 
C17H15BrF2N4O3
 
10288191 
Moderate    Inter Info   
[3], [10], [48]
D0199
 
Brentuximab vedotin
 
NA
 
NA
Moderate    Inter Info   
[49], [50]
D0425
 
Darolutamide
 
C19H19ClN6O2
 
67171867 
Moderate    Inter Info   
[10], [51]
D0558
 
Elexacaftor
 
C26H34F3N7O4S
 
134587348 
Moderate    Inter Info   
[52], [53], [54]
D0568
 
Enasidenib
 
C19H17F6N7O
 
89683805 
Moderate    Inter Info   
[3], [55], [50]
D0569
 
Encorafenib
 
C22H27ClFN7O4S
 
50922675 
Moderate    Inter Info   
[10], [56]
D0577
 
Entrectinib
 
C31H34F2N6O2
 
25141092 
Moderate    Inter Info   
[3], [10], [57]
D0700
 
Fostemsavir
 
C25H26N7O8P
 
11319217 
Moderate    Inter Info   
[58]
D0963
 
Lusutrombopag
 
C29H32Cl2N2O5S
 
49843517 
Moderate    Inter Info   
[61]
D1062
 
Midostaurin
 
C35H30N4O4
 
9829523 
Moderate    Inter Info   
[10]
D1258
 
Pexidartinib
 
C20H15ClF3N5
 
25151352 
Moderate    Inter Info   
[4], [63]
D1301
 
Pitavastatin
 
C25H24FNO4
 
5282452 
Moderate    Inter Info   
[4]
D1396
 
Revefenacin
 
C35H43N5O4
 
11753673 
Moderate    Inter Info   
[46], [17], [64]
D1409
 
Ripretinib
 
C24H21BrFN5O2
 
71584930 
Moderate    Inter Info   
[3], [65]
D1436
 
Sacubitril
 
C24H29NO5
 
9811834 
Moderate    Inter Info   
[3], [46], [17]
D1532
 
Talazoparib
 
C19H14F2N6O
 
135565082 
Moderate    Inter Info   
[66]
D1663
 
Ubrogepant
 
C29H26F3N5O3
 
68748835 
Moderate    Inter Info   
[67]
D1710
 
Voxilaprevir
 
C40H52F4N6O9S
 
89921642 
Moderate    Inter Info   
[68]
      Affected intra/extra-hepatic metabolism
   CYP450 enzyme inhibition Drug Num:  66
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0080
 
Amprenavir
 
C25H35N3O6S
 
65016 
Major    Inter Info   
[3], [4], [5]
D0116
 
Atazanavir
 
C38H52N6O7
 
148192 
Major    Inter Info   
[3], [4], [5]
D0120
 
Atorvastatin
 
C33H35FN2O5
 
60823 
Major    Inter Info   
[4]
D0342
 
Cisapride
 
C23H29ClFN3O4
 
6917698 
Major    Inter Info   
[7], [8], [9]
D0349
 
Clarithromycin
 
C38H69NO13
 
84029 
Major    Inter Info   
[3], [4], [5]
D0386
 
Conivaptan
 
C32H26N4O2
 
151171 
Major    Inter Info   
[3], [4], [5]
D0402
 
Cyclosporine
 
C62H111N11O12
 
5284373 
Major    Inter Info   
[3], [10], [4]
D0426
 
Darunavir
 
C27H37N3O7S
 
213039 
Major    Inter Info   
[3], [4], [5]
D0439
 
Delavirdine
 
C22H28N6O3S
 
5625 
Major    Inter Info   
[3], [4], [5]
D0597
 
Erythromycin
 
C37H67NO13
 
12560 
Major    Inter Info   
[3], [4], [5]
D0667
 
Fluconazole
 
C13H12F2N6O
 
3365 
Major    Inter Info   
[3], [4], [5]
D0692
 
Fosamprenavir
 
C25H36N3O9PS
 
131536 
Major    Inter Info   
[3], [4], [5]
D0799
 
Indinavir
 
C36H47N5O4
 
5362440 
Major    Inter Info   
[3], [4], [5]
D0867
 
Itraconazole
 
C35H38Cl2N8O4
 
55283 
Major    Inter Info   
[3], [4], [5]
D0880
 
Ketoconazole
 
C26H28Cl2N4O4
 
456201 
Major    Inter Info   
[3], [4], [5]
D1117
 
Nefazodone
 
C25H32ClN5O2
 
4449 
Major    Inter Info   
[3], [4], [5]
D1119
 
Nelfinavir
 
C32H45N3O4S
 
64143 
Major    Inter Info   
[3], [4], [5]
D1315
 
Posaconazole
 
C37H42F2N8O4
 
468595 
Major    Inter Info   
[3], [4], [5]
D1415
 
Ritonavir
 
C37H48N6O5S2
 
392622 
Major    Inter Info   
[3], [4], [5]
D1444
 
Saquinavir
 
C38H50N6O5
 
441243 
Major    Inter Info   
[3], [4], [5]
D0192
 
Boceprevir
 
C27H45N5O5
 
10324367 
Major    Inter Info   
[3], [4], [5]
D0375
 
Cobicistat
 
C40H53N7O5S2
 
25151504 
Major    Inter Info   
[3], [4], [5]
D0543
 
Duvelisib
 
C22H17ClN6O
 
50905713 
Major    Inter Info   
[3], [4], [5]
D0638
 
Fedratinib
 
C27H36N6O3S
 
16722836 
Major    Inter Info   
[3], [4], [5]
D1653
 
Troleandomycin
 
C41H67NO15
 
202225 
Major    Inter Info   
[3], [4], [5]
D1660
 
Tucatinib
 
C26H24N8O2
 
51039094 
Major    Inter Info   
[3], [4], [5]
D1709
 
Voxelotor
 
C19H19N3O3
 
71602803 
Major    Inter Info   
[3], [4], [5]
D1541
 
Telaprevir
 
C36H53N7O6
 
3010818 
Major    Inter Info   
[3], [4], [5]
D1544
 
Telithromycin
 
C43H65N5O10
 
3002190 
Major    Inter Info   
[3], [4], [5]
D1706
 
Voriconazole
 
C16H14F3N5O
 
71616 
Major    Inter Info   
[3], [4], [5]
D0066
 
Amiodarone
 
C25H29I2NO3
 
2157 
Moderate    Inter Info   
[4]
D0069
 
Amlodipine
 
C20H25ClN2O5
 
2162 
Moderate    Inter Info   
[4]
D0128
 
Avanafil
 
C23H26ClN7O3
 
9869929 
Moderate    Inter Info   
[4]
D0170
 
Bepridil
 
C24H34N2O
 
2351 
Moderate    Inter Info   
[25], [26], [4]
D0303
 
Cerivastatin
 
C26H34FNO5
 
446156 
Moderate    Inter Info   
[27], [4], [28]
D0376
 
Cobimetinib
 
C21H21F3IN3O2
 
16222096 
Moderate    Inter Info   
[29]
D0497
 
Diltiazem
 
C22H26N2O4S
 
39186 
Moderate    Inter Info   
[4]
D0508
 
Disopyramide
 
C21H29N3O
 
3114 
Moderate    Inter Info   
[4]
D0629
 
Everolimus
 
C53H83NO14
 
6442177 
Moderate    Inter Info   
[3], [10], [4]
D0640
 
Felodipine
 
C18H19Cl2NO4
 
3333 
Moderate    Inter Info   
[4]
D0664
 
Flecainide
 
C17H20F6N2O3
 
3356 
Moderate    Inter Info   
[4]
D0865
 
Isradipine
 
C19H21N3O5
 
3784 
Moderate    Inter Info   
[4]
D0956
 
Lovastatin
 
C24H36O5
 
53232 
Moderate    Inter Info   
[4]
D1054
 
Mexiletine
 
C11H17NO
 
4178 
Moderate    Inter Info   
[4]
D1060
 
Midazolam
 
C18H13ClFN3
 
4192 
Moderate    Inter Info   
[4]
D1130
 
Nicardipine
 
C26H29N3O6
 
4474 
Moderate    Inter Info   
[4]
D1134
 
Nifedipine
 
C17H18N2O6
 
4485 
Moderate    Inter Info   
[4]
D1138
 
Nimodipine
 
C21H26N2O7
 
4497 
Moderate    Inter Info   
[4]
D1141
 
Nisoldipine
 
C20H24N2O6
 
4499 
Moderate    Inter Info   
[4]
D1203
 
Oxycodone
 
C18H21NO4
 
5284603 
Moderate    Inter Info   
[3], [10], [43]
D1353
 
Propafenone
 
C21H27NO3
 
4932 
Moderate    Inter Info   
[4]
D1371
 
Quinidine
 
C20H24N2O2
 
441074 
Moderate    Inter Info   
[4]
D1465
 
Sildenafil
 
C22H30N6O4S
 
135398744 
Moderate    Inter Info   
[4]
D0038
 
Aliskiren
 
C30H53N3O6
 
5493444 
Moderate    Inter Info   
[11], [10], [44], [45]
D0720
 
Gilteritinib
 
C29H44N8O3
 
49803313 
Moderate    Inter Info   
[10], [59]
D0899
 
Lefamulin
 
C28H45NO5S
 
25185057 
Moderate    Inter Info   
[60]
D0911
 
Levamlodipine
 
C20H25ClN2O5
 
9822750 
Moderate    Inter Info   
[4]
D1065
 
Milk thistle
 
C25H22O10
 
1548994 
Moderate    Inter Info   
[4]
D1101
 
Naldemedine
 
C32H34N4O6
 
54732242 
Moderate    Inter Info   
[10], [62]
D1473
 
Simvastatin
 
C25H38O5
 
54454 
Moderate    Inter Info   
[4]
D1476
 
Sirolimus
 
C51H79NO13
 
5284616 
Moderate    Inter Info   
[3], [10], [4]
D1526
 
Tacrolimus
 
C44H69NO12
 
445643 
Moderate    Inter Info   
[3], [10], [4]
D1527
 
Tadalafil
 
C22H19N3O4
 
110635 
Moderate    Inter Info   
[4]
D1632
 
Triazolam
 
C17H12Cl2N4
 
5556 
Moderate    Inter Info   
[4]
D1682
 
Vardenafil
 
C23H32N6O4S
 
135400189 
Moderate    Inter Info   
[4]
D1690
 
Verapamil
 
C27H38N2O4
 
2520 
Moderate    Inter Info   
[4]
   CYP450 enzyme induction Drug Num:  20
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0255
 
Carbamazepine
 
C15H12N2O
 
2554 
Major    Inter Info   
[4], [6]
D0453
 
Dexamethasone
 
C22H29FO5
 
5743 
Major    Inter Info   
[4], [6]
D0554
 
Efavirenz
 
C14H9ClF3NO2
 
64139 
Major    Inter Info   
[4], [6]
D0697
 
Fosphenytoin
 
C16H15N2O6P
 
56339 
Major    Inter Info   
[4], [6]
D1078
 
Mitotane
 
C14H10Cl4
 
4211 
Major    Inter Info   
[4], [6]
D1128
 
Nevirapine
 
C15H14N4O
 
4463 
Major    Inter Info   
[4], [6]
D1198
 
Oxcarbazepine
 
C15H12N2O2
 
34312 
Major    Inter Info   
[4], [6]
D1265
 
Phenobarbital
 
C12H12N2O3
 
4763 
Major    Inter Info   
[4], [6]
D1283
 
Phenytoin
 
C15H12N2O2
 
1775 
Major    Inter Info   
[4], [6]
D1340
 
Primidone
 
C12H14N2O2
 
4909 
Major    Inter Info   
[4], [6]
D1399
 
Rifabutin
 
C46H62N4O11
 
135398743 
Major    Inter Info   
[4], [6]
D1400
 
Rifampicin
 
C43H58N4O12
 
135398735 
Major    Inter Info   
[11], [4], [6]
D1401
 
Rifapentine
 
C47H64N4O12
 
135403821 
Major    Inter Info   
[4], [6]
D0095
 
Apalutamide
 
C21H15F4N5O2S
 
24872560 
Major    Inter Info   
[4], [6]
D0578
 
Enzalutamide
 
C21H16F4N4O2S
 
15951529 
Major    Inter Info   
[4], [6]
D0601
 
Eslicarbazepine
 
C15H14N2O2
 
9881504 
Major    Inter Info   
[4], [6]
D0628
 
Etravirine
 
C20H15BrN6O
 
193962 
Major    Inter Info   
[4], [6]
D0958
 
Lumacaftor
 
C24H18F2N2O5
 
16678941 
Major    Inter Info   
[11], [4], [6]
D1502
 
St. John's Wort
 
NA
 
NA
Major    Inter Info   
[4], [6]
D1592
 
Tipranavir
 
C31H33F3N2O5S
 
54682461 
Major    Inter Info   
[4], [6]
      Pharmacodynamic additive effects
   Increased risk of photosensitivity reactions Drug Num:  5
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0062
 
Aminolevulinic acid
 
C5H9NO3
 
137 
Major    Inter Info   
[1], [2]
D0063
 
Aminolevulinic acid (topical)
 
C5H9NO3
 
137 
Moderate    Inter Info   
[3], [10], [22]
D1028
 
Methoxsalen
 
C12H8O4
 
4114 
Moderate    Inter Info   
[3], [40], [1], [41], [42]
D1033
 
Methyl aminolevulinate (topical)
 
C6H11NO3
 
157922 
Moderate    Inter Info   
[3], [10], [22]
D1691
 
Verteporfin
 
C82H84N8O16
 
11980904 
Moderate    Inter Info   
[10], [40], [1], [69]
      Pharmacodynamic antagonistic effects
   Antagonize the effect of antithrombotic agents Drug Num:  3
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0087
 
Anisindione
 
C16H12O3
 
2197 
Moderate    Inter Info   
[10], [23], [24]
D0481
 
Dicoumarol
 
C19H12O6
 
54676038 
Moderate    Inter Info   
[10], [23], [24]
D1711
 
Warfarin
 
C19H16O4
 
54678486 
Moderate    Inter Info   
[70], [3], [10], [71], [24], [4], [72]
References
1 Product Information. Nulibry (fosdenopterin). Origin Biosciences Inc, Boston, MA.
2 Product Information. Gleolan (aminolevulinic acid). NX Development Corp, Lexington, KY.
3 Cerner Multum, Inc. "Australian Product Information.".
4 Product Information. Olysio (simeprevir). Janssen Pharmaceuticals, Titusville, NJ.
5 Product Information. Sporanox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
6 Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
7 Bedford TA, Rowbotham DJ "Cisapride: drug interactions of clinical significance." Drug Saf 15 (1996): 167-75. [PMID: 8879971]
8 Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
9 Thomas AR, Chan LN, Bauman JL, Olopade CO "Prolongation of the QT interval related to cisapride-diltiazem interaction." Pharmacotherapy 18 (1998): 381-5. [PMID: 9545159]
10 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
11 Canadian Pharmacists Association.
12 Mendell J, Zahir H, Matsushima N, et al. "Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor." Am J Cardiovasc Drugs (2013):. [PMID: 23784266]
13 Parasrampuria DA, Mendell J, Shi M, Matsushima N, Zahir H, Truitt K "Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine." Br J Clin Pharmacol 0 (2016): epub. [PMID: 27530188]
14 Product Information. Savaysa (edoxaban). Daiichi Sankyo, Inc., Parsippany, NJ.
15 Davenport JM, Covington P, Bonifacio L, McIntyre G, Venitz J "Effect of uptake transporters OAT3 and OATPIBI and efflux transporter MRP2 on the pharmacokinetics of eluxadoline." J Clin Pharmacol 55 (2015): 534-42. [PMID: 25491493]
16 Product Information. Viberzi (eluxadoline). Actavis Pharma, Inc., Parsippany, NJ.
17 Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
18 Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
19 Product Information. Harvoni (ledipasvir-sofosbuvir). Gilead Sciences, Foster City, CA.
20 Product Information. Orgovyx (relugolix). Myovant Sciences, Inc., Brisbane, CA.
21 Product Information. Venclexta (venetoclax). AbbVie US LLC, North Chicago, IL.
22 Product Information. Metvixia (methyl aminolevulinate topical). Galderma Laboratories Inc, Cranbury, NJ.
23 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
24 Product Information. Incivek (telaprevir). Vertex Pharmaceuticals, Cambridge, MA.
25 Ace LN, Jaffe JM, Kunka RL "Effect of food and an antacid on quinidine bioavailability." Biopharm Drug Dispos 4 (1983): 183-90. [PMID: 6882885]
26 Min DI, Ku YM, Geraets DR, Lee HC "Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers." J Clin Pharmacol 36 (1996): 469-76. [PMID: 8739026]
27 Neuvonen PJ, Backman JT, Niemi M "Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin." Clin Pharmacokinet 47 (2008): 463-74. [PMID: 18563955]
28 Richter WO, Jacob BG, Schwandt P "Interaction between fibre and lovastatin." Lancet 338 (1991): 706. [PMID: 1679514]
29 Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
30 Aronson JK, Grahame-Smith DG "Clinical pharmacology: adverse drug interactions." Br Med J 282 (1981): 288-91. [PMID: 6779990]
31 Engels FK, Mathot RA, Loos WJ, van Schaik RH, Verweij J "Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel." Cancer Biol Ther 5 (2006): 833-9. [PMID: 16775418]
32 McInnes GT, Brodie MJ "Drug interactions that matter: a critical reappraisal." Drugs 36 (1988): 83-110. [PMID: 3063497]
33 Product Information. Taxotere (docetaxel). Rhone-Poulenc Rorer, Collegeville, PA.
34 Starr SP, Hammann F, Gotta V, et al. "Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity." Br J Clin Pharmacol 450 (2016): 22-27. [PMID: 27868228]
35 Vodovar D, Arnaout M, Mongardon N, et al. "Severe docetaxel overdose induced by pharmacokinetic interaction with dronedarone." J Clin Oncol 29 (2011): e694-5. [PMID: 21730272]
36 Yong WP, Wang LZ, Tham LS, et al. "A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers." Cancer Chemother Pharmacol 62 (2008): 243-51. [PMID: 17909805]
37 Allred AJ, Bowen CJ, Park JW, et al. "Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers." Br J Clin Pharmacol 72 (2011): 321-9. [PMID: 21434975]
38 Kalliokoski A, Niemi M "Impact of OATP transporters on pharmacokinetics." Br J Pharmacol 158 (2009): 693-705. [PMID: 19785645]
39 Product Information. Promacta (eltrombopag). GlaxoSmithKline, Research Triangle Park, NC.
40 Multum Information Services, Inc. Expert Review Panel.
41 Product Information. Oxsoralen (methoxsalen). ICN Pharmaceuticals Inc, Costa Mesa, CA.
42 Product Information. Uvadex (methoxsalen). Therakos Inc, Exton, PA.
43 Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
44 Product Information. Tekturna (aliskiren). Novartis Pharmaceuticals, East Hanover, NJ.
45 Tapaninen T, Backman JT, Kurkinen K, Neuvonen P, Niemi M "Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren." J Clin Pharmacol 51 (2011): 359-67. [PMID: 20400651]
46 Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
47 Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
48 Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
49 Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
50 Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
51 Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
52 Product Information. Cozaar (losartan). Merck &amp Co, Inc, West Point, PA.
53 Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
54 Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
55 Product Information. Idhifa (enasidenib). Celgene Corporation, Summit, NJ.
56 Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
57 Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
58 Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
59 Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
60 Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
61 EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
62 Product Information. Symproic (naldemedine). Shionogi USA Inc, Florham Park, NJ.
63 Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
64 Product Information. Yupelri (revefenacin). Mylan Specialty, Morgantown, WV.
65 Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
66 Product Information. Talzenna (talazoparib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
67 Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
68 Product Information. Vosevi (sofosbuvir/velpatasvir/voxilaprevir). Gilead Sciences, Foster City, CA.
69 Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
70 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
71 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
72 Product Information. Victrelis (boceprevir). Schering-Plough Corporation, Kenilworth, NJ.